The National Times - France's Sanofi to seek Covid vaccine approval after delays

France's Sanofi to seek Covid vaccine approval after delays


France's Sanofi to seek Covid vaccine approval after delays
France's Sanofi to seek Covid vaccine approval after delays

French pharmaceuticals giant Sanofi said Wednesday that its Covid-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.

Change text size:

The two drugmakers said they will "seek regulatory authorisation" for their vaccine in the United States and the European Union following phase 3 trials involving thousands of people.

The trials indicated that the vaccine was 100 percent effective against severe Covid disease and hospitalisation, Sanofi said in a statement.

It was also more than 50 percent effective against all symptomatic Covid, the statement added.

Sanofi's vice-president for vaccines Thomas Triomphe said the data was "similar to the recent clinical data from authorised vaccines".

He also emphasised that no other phase 3 study "has been undertaken during this period with so many variants of concern, including Omicron."

The announcement of the positive trials -- which have not yet been released as is normal practice -- puts the vaccine on the last hurdle before a possible market launch.

Sanofi's share price rose nearly 1.5 percent on the Paris stock exchange at midday.

- Wounded French pride -

If the vaccine receives authorisation, it will mark the end of Sanofi's long struggle to develop a Covid vaccine following numerous setbacks.

The French firm originally hoped to announce such results by mid-2021.

But the date was pushed back by six months due to a dosing error, then late last year was delayed again after difficulties finding people who had never been infected with Covid to take part in the trials.

The delays -- and the renowned Pasteur Institute abandoning plans to develop its own vaccine in early 2021 -- dented the pride of a country that considers itself a leader on pharmaceutical technology.

Sanofi also abandoned a previous vaccine project based on the mRNA technology used by its quicker rivals Pfizer/BioNTech and Moderna, whose jabs have formed the backbone of vaccination efforts in many countries.

Sanofi is now focused on a vaccine using a slightly less innovative technique based on recombinant protein technology, also seen in the Novavax jab which is about to be introduced in France.

There are hopes that Sanofi's jab could appeal more to unvaccinated people who remain sceptical of mRNA technology, despite the reams of evidence on its effectiveness.

GlaxoSmithKline's vaccines head Roger Connor said in the statement that the jab "uses a well-established approach that has been applied widely to prevent infection with other viruses including pandemic flu".

The EU has already pre-ordered millions of doses of the vaccine, and Sanofi is likely to play a role in booster campaigns around the world.

And with many countries -- particularly in the developing world -- struggling to inoculate their population, there is likely still a market for newer vaccines.

K.M.Thompson--TNT

Featured

Scottish Woman Bought Dubai Apartment for Under Dh1 Million in 'Real Centre of City'

Scottish national Kelly Lundberg purchased a one-bedroom apartment in Dubai’s Jumeirah Village Circle (JVC) for just under Dh1 million ($272,294) in 2013 as an investment. After living in various locations across the city since 2003, she moved into the property during the pandemic in 2020 and has since transformed it into her primary residence, citing its light, outdoor space, and location as key factors.

RegioJet Takes Over Prague–Jihlava–Brno R9 Line in December

Private rail operator RegioJet is set to take over services on the Prague–Jihlava–Brno R9 line starting December 13, 2026. The transition brings direct connections and upgraded passenger amenities, although the introduction of new PESA electric trains has been postponed until 2027 due to testing requirements.

Egypt's Baraka Oilfield Output Surges 180% After New Well Activation

Egypt’s South Valley Egyptian Petroleum Holding Company (GANOPE) reported an 180 percent increase in production at the Baraka field in Aswan Governorate. The surge follows the successful drilling and start-up of the development well Baraka-19, which has raised daily output to more than 600 barrels of crude oil.

Langley Businesses Navigate Tariff Pressures Amid Holiday Shopping Push

Independent businesses in Langley are facing heightened financial pressures from recent tariff implementations as they navigate the crucial holiday shopping period. While supply chain disruptions threaten inventory and pricing, local advocates highlight that spending at community retailers recirculates significantly more wealth within the region than purchases made through multinational or online platforms.

Change text size: